Skip to main content

Table 1 Description of the main characteristics in the prospective and ambispective MARTHA samples

From: Association of ABO blood groups with venous thrombosis recurrence in middle-aged patients: insights from a weighted Cox analysis dedicated to ambispective design

Variables

MARTHA Prospective sample

MARTHA Ambispective sample

Total

N = 839

Recurrences

N = 159

Non-recurrences

N = 680

Total

N = 1,504

Recurrences

N = 565

Non-recurrences

N = 939

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

Gender

 Men

275 (32.8%)

63 (39.6%)

212 (31.2%)

509 (33.8%)

232 (41.1%)

277 (29.5%)

Age at inclusion (mean ± SD)

45.2 ± 14.9

44.0 ± 13.9

45.5 ± 15.4

47.1 ± 15.4

50.0 ± 14.7

45.3 ± 15.5

Age at the first VT (mean ± SD)

42.3 ± 15.5

41.5 ± 14.4

42.5 ± 15.8

41.0 ± 15.7

40.5 ± 15.1

41.3 ± 16.0

Delay between inclusion and first VT

(In years, mean ± SD)

2.9 ± 6.2

2.5 ± 5.3

3.0 ± 6.4

6.1 ± 9.85

9.5 ± 11.3

4.0 ± 8.2

Type of the first VT

 DVT

653 (77.8%)

122 (76.7%)

531 (78.1%)

1,189 (79.1%)

454 (80.4%)

735 (78.3%)

Characteristic of the first VT

 Provoked

544 (64.8%)

93 (58.5%)

451 (66.3%)

993 (66.0%)

368 (65.1%)

625 (66.6%)

Age at the collection of information on recurrence (mean ± SD)a

54.9 ± 15.2

54.9 ± 13.9

54.9 ± 15.5

52.5 ± 15.6

43.0 ± 14.2

52.1 ± 16.4

Delay of follow-up in yearsb

(In years, mean ± SD)

8.8 ± 5.5

6.4 ± 5.3

9.4 ± 5.4

9.7 ± 9.6

7.9 ± 8.9

10.8 ± 9.8

ABO haplotypes

 A1

32.8%

37.4%

31.7%

33.5%

35.8%

32.2%

 A2

5.5%

5.3%

5.5%

5.9%

6.9%

5.3%

 O1

51.0%

47.5%

51.8%

49.8%

46.9%

51.5%

 O2

1.7%

1.6%

1.7%

1.5%

1.5%

1.5%

 B

9.1%

8.2%

9.3%

9.3%

8.9%

9.5%

  1. aSince inclusion in the prospective sample, since the first VT in the ambispective sample
  2. bRefers to the recontact for Cases 1 & 2 and inclusion for Cases 3 & 4 (see Fig. 1)